Given that BTN2A1/BTN3A1 is vital for the success of Vγ9Vδ2 T-cell immunotherapy against NPC, thus, we continued to explore if other EBV genes can directly influence their expression. This evidence concerns the gene BTN3A1 and nasopharyngeal carcinoma.